全部文献期刊学位论文会议报纸专利标准年鉴图书|学者科研项目
中外文文献  中文文献  外文文献
作者:Clémentine Mirabel , Joaquim Vives
来源:[J].Stem Cell Research & Therapy(IF 3.652), 2017, Vol.8 (1)Springer
摘要:For years, sufficient progress has been made in treating heart failure following myocardial infarction; however, the social and economic burdens and the costs to world health systems remain high. Moreover, treatment advances have not resolved the underlying problem of functional ...
作者:Clémentine Mirabel , Joaquim Vives
来源:[J].Stem Cell Research & Therapy(IF 3.652), 2017, Vol.8 (1), pp.1-11DOAJ
摘要:Abstract For years, sufficient progress has been made in treating heart failure following myocardial infarction; however, the social and economic burdens and the costs to world health systems remain high. Moreover, treatment advances have not resolved the underlying problem of fu...
作者:Clémentine Mirabel , Margarita Blanco ...
来源:[J].Cells, 2019, Vol.8 (5)DOAJ
摘要:Background : The selection of assays suitable for testing the potency of clinical grade multipotent mesenchymal stromal cell (MSC)-based products and its interpretation is a challenge for both developers and regulators. Here, we present a bioprocess design for the production...
作者:Clémentine Mirabel , Eduard Puente-Massaguer ...
来源:[J].2018, Vol.16 (1), pp.291BMC
摘要:Successful delivery of cell-based therapeutics into patients is compromised by their short shelf-life upon release from production facilities due to the living nature of the active component that rapidly loses viability, and therefore its properties. In this context, the use...
作者:Clémentine Mirabel , Joaquim Vives
来源:[J].2017, Vol.8 (1), pp.238BMC
摘要:For years, sufficient progress has been made in treating heart failure following myocardial infarction; however, the social and economic burdens and the costs to world health systems remain high. Moreover, treatment advances have not resolved the underlying problem of functional ...
作者:Joaquim Vives , Clémentine Mirabel
来源:[B].Reference Module in Biomedical Research2015Elsevier
摘要:Bone marrow-derived Mesenchymal Stromal Cells (BM-MSC) are multipotent cells present in the marrow stroma with potential therapeutic use in pathologies not necessarily restricted to bone and hematopoiesis dysfunctions. However, only a couple of BM-MSC-based products have received...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×